BridgeBio Pharma BBIO
NASDAQ BBIO
$66.29 +0.32 (+0.48%)
As of: Sep 30, 2026 · 10:25 AM EDT

BridgeBio Pharma (BBIO) Other financing activities (2018 - 2026)

Updated

BridgeBio Pharma's Other financing activities came in at $4.27 million for Q2 2026, up 113.9% from $2 million a year earlier and up 4.7% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Other financing activities (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BridgeBio Pharma reported Other financing activities of $18.8 million, up 184.0% year-over-year; for FY2025, it came in at $14.23 million, up 89.0% from FY2024.

  • Other financing activities has increased in each of the last three years, though with a five-year compound annual growth rate of -10.0% (FY2020 to FY2025).
  • Going back by year, Other financing activities was $7.53 million in FY2024 (+9.4%), $6.88 million in FY2023 (+340.7%), $1.56 million in FY2022 (-90.3%) and $16.06 million in FY2021 (-33.3%).
  • The five-year range for quarterly Other financing activities is -$238,000 (Q3 2023) to $7.43 million (Q4 2025).
  • Year-over-year, Other financing activities has increased for five consecutive quarters, with growth averaging 101.7% over the last seven quarters.
  • The fastest year-over-year change in Other financing activities over five years came in Q4 2023 (growth of 479.4%), and the weakest in Q1 2022 (a decline of 93.0%).
  • Business Quant data shows BBIO's Other financing activities at $4.07 million (Q1 2026), $7.43 million (Q4 2025) and $3.03 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.27 Mn
Mar 31, 2026 4.07 Mn
Dec 31, 2025 7.43 Mn
Sep 30, 2025 3.03 Mn
Jun 30, 2025 2.00 Mn
Mar 31, 2025 1.78 Mn
Dec 31, 2024 1.40 Mn
Sep 30, 2024 1.44 Mn
Jun 30, 2024 1.74 Mn
Mar 31, 2024 2.94 Mn
Dec 31, 2023 2.56 Mn
Sep 30, 2023 -238,000.00
Jun 30, 2023 1.20 Mn
Mar 31, 2023 5.74 Mn
Dec 31, 2022 441,000.00
Sep 30, 2022 596,000.00
Jun 30, 2022 366,000.00
Mar 31, 2022 1.12 Mn
Sep 30, 2021 734,000.00
Mar 31, 2021 16.06 Mn
API Access

BridgeBio Pharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=BBIO&period=max&api_key=YOUR_API_KEY